Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3487411011 | Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3677808015 | Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Is a | Product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 5 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 5 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 5 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 6 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 6 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 6 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 7 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 7 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 7 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has active ingredient | Cobicistat | false | Inferred relationship | Existential restriction modifier | 8 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Cobicistat | false | Inferred relationship | Existential restriction modifier | 8 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 8 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 8 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 8 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 8 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has active ingredient | Elvitegravir | false | Inferred relationship | Existential restriction modifier | 6 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Elvitegravir | false | Inferred relationship | Existential restriction modifier | 6 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 6 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has active ingredient | Emtricitabine | false | Inferred relationship | Existential restriction modifier | 7 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Emtricitabine | false | Inferred relationship | Existential restriction modifier | 7 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 7 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has active ingredient | Tenofovir alafenamide | false | Inferred relationship | Existential restriction modifier | 5 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Tenofovir alafenamide | false | Inferred relationship | Existential restriction modifier | 5 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 5 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 4 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 4 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 4 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Cobicistat | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has precise active ingredient | Cobicistat | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Emtricitabine | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has precise active ingredient | Elvitegravir | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Elvitegravir | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has precise active ingredient | Emtricitabine | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 4 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has precise active ingredient | Tenofovir alafenamide | true | Inferred relationship | Existential restriction modifier | 4 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Tenofovir alafenamide | true | Inferred relationship | Existential restriction modifier | 4 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 4 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Is a | Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Cobicistat | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has basis of strength substance | Emtricitabine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has precise active ingredient | Emtricitabine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet | Has precise active ingredient | Cobicistat | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR